PharmaTimes August 8, 2024
The study predicted the development of conditions including Alzheimer’s and heart disease
Researchers from the University of Edinburgh, along with commercial collaborators Optima Partners and Biogen, have revealed that artificial intelligence (AI) insights can predict a person’s disease’s development a decade in advance.
Using AI and machine learning tools to identify protein patterns in the blood, researchers have been able to predict the development of conditions such as Alzheimer’s disease (AD), heart disease and type 2 diabetes (T2D) prior to diagnosis.
Combined, conditions including dementia, heart and circulatory disease and diabetes are estimated to affect nearly 13 million people living in the UK.
The study, published in Nature Aging and funded by Wellcome, analysed blood samples from the UK Biobank...